Literature DB >> 8625040

Prognostic evaluation of DNA flow cytometric and histopathologic parameters of colorectal cancer.

R Tang1, Y S Ho, Y T You, K C Hsu, J S Chen, C R Changchien, J Y Wang.   

Abstract

BACKGROUND: The clinical value of DNA flow cytometry of colorectal cancer is unclear. The purpose of this retrospective study was to evaluate the relationship between tumor flow cytometry, histopathologic parameters, and survival.
METHODS: Flow cytometry was performed on paraffin embedded specimens from 653 patients who had surgery from 1980 to 1983.
RESULTS: Aneuploidy was associated with distal tumor, perineural invasion, desmoplastic reaction, and failure to secrete mucin. TNM Stage I tumors were more frequently diploid than were more advanced tumors (71% vs. 41%). An abnormal DNA content had a marginal impact on survival as evaluated by univariate analysis (69% vs. 61% 10-year survival rate, P = 0.06). Multivariate analysis revealed that significant predictors of outcome were lymph node metastasis (95% confidence interval of relative risks of death from recurrent disease, 1.50-2.92), rectal cancer (1.22-2.19), absence of lymphocytic infiltration (1.20-2.17), invasion through bowel wall (1.17-3.13), lymphatic vessel invasion outside bowel wall (1.05-2.69), perineural invasion (1.15-3.19), and male gender (1.00-1.79).
CONCLUSIONS: These findings suggest that ploidy is associated with some histopathologic parameters, but flow cytometry does not correlate with long term survival of patients with colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8625040     DOI: 10.1002/1097-0142(19951115)76:10<1724::aid-cncr2820761008>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  DNA content analysis of colorectal cancer defines a distinct 'microsatellite and chromosome stable' group but does not predict response to radiotherapy.

Authors:  Wakkas Fadhil; Karin Kindle; Darryl Jackson; Abed Zaitoun; Nina Lane; Adrian Robins; Mohammad Ilyas
Journal:  Int J Exp Pathol       Date:  2014-02       Impact factor: 1.925

2.  Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.

Authors:  M Minagawa; M Makuuchi; G Torzilli; T Takayama; S Kawasaki; T Kosuge; J Yamamoto; H Imamura
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

3.  DNA index and S-phase fraction in curative resection of colorectal adenocarcinoma: analysis of prognosis and current trends.

Authors:  Han-Shiang Chen; Shyr-Ming Sheen-Chen; Chen-Chang Lu
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

Review 4.  Stage-specific frequency and prognostic significance of aneuploidy in patients with sporadic colorectal cancer--a meta-analysis and current overview.

Authors:  Tilman Laubert; Sandra Freitag-Wolf; Michael Linnebacher; Alexandra König; Brigitte Vollmar; Jens K Habermann
Journal:  Int J Colorectal Dis       Date:  2015-06-09       Impact factor: 2.571

Review 5.  Chromosome Instability; Implications in Cancer Development, Progression, and Clinical Outcomes.

Authors:  Raghvendra Vishwakarma; Kirk J McManus
Journal:  Cancers (Basel)       Date:  2020-03-29       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.